JP2022164858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022164858A5 JP2022164858A5 JP2022139098A JP2022139098A JP2022164858A5 JP 2022164858 A5 JP2022164858 A5 JP 2022164858A5 JP 2022139098 A JP2022139098 A JP 2022139098A JP 2022139098 A JP2022139098 A JP 2022139098A JP 2022164858 A5 JP2022164858 A5 JP 2022164858A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662325428P | 2016-04-20 | 2016-04-20 | |
US62/325,428 | 2016-04-20 | ||
JP2018554677A JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性il2r融合タンパク質およびその使用 |
PCT/US2017/028693 WO2017184901A1 (en) | 2016-04-20 | 2017-04-20 | Immunomodulatory il2r fusion proteins and uses thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018554677A Division JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性il2r融合タンパク質およびその使用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022164858A JP2022164858A (ja) | 2022-10-27 |
JP2022164858A5 true JP2022164858A5 (ja) | 2023-06-27 |
Family
ID=58710057
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018554677A Active JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性il2r融合タンパク質およびその使用 |
JP2022139098A Pending JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性il2r融合タンパク質およびその使用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018554677A Active JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性il2r融合タンパク質およびその使用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190127435A1 (ja) |
EP (1) | EP3445847A1 (ja) |
JP (2) | JP7198670B2 (ja) |
CN (1) | CN109312304A (ja) |
CA (1) | CA3021455A1 (ja) |
WO (1) | WO2017184901A1 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY196588A (en) * | 2015-03-05 | 2023-04-19 | Hutchinson Fred Cancer Res | Immunomodulatory Fusion Proteins and uses Thereof |
AU2018236461A1 (en) | 2017-03-17 | 2019-09-19 | Fred Hutchinson Cancer Center | Immunomodulatory fusion proteins and uses thereof |
CN109503715B (zh) * | 2017-09-15 | 2023-12-15 | 科济生物医药(上海)有限公司 | Il-4r的融合蛋白及其应用 |
CN108504685A (zh) * | 2018-03-27 | 2018-09-07 | 宜明细胞生物科技有限公司 | 一种利用CRISPR/Cas9系统同源重组修复IL-2RG缺陷基因的方法 |
CN110615843B (zh) * | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含第三信号受体的嵌合抗原受体及其应用 |
CN110582515A (zh) * | 2018-11-12 | 2019-12-17 | 天境生物科技(上海)有限公司 | 包含cd47抗体和细胞因子的融合蛋白 |
KR20220028090A (ko) * | 2019-06-28 | 2022-03-08 | 카파 테라퓨틱스 리미티드 | 이식 반응에 저항하는 세포 및 방법 |
US20210238258A1 (en) * | 2019-09-11 | 2021-08-05 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric orthogonal receptor proteins and methods of use |
WO2021055372A1 (en) * | 2019-09-16 | 2021-03-25 | Fred Hutchinson Cancer Research Center | Chimeric receptor proteins and uses thereof |
US20230030680A1 (en) * | 2020-01-07 | 2023-02-02 | St. Jude Children's Research Hospital, Inc | Chimeric gmcsf-il18 receptor |
CN113249330A (zh) * | 2021-05-20 | 2021-08-13 | 深圳市先康达生命科学有限公司 | 免疫细胞及其应用 |
WO2023081727A1 (en) * | 2021-11-02 | 2023-05-11 | Fred Hutchinson Cancer Center | Treatments for cancers utilizing cell-targeted therapies and associated research protocols |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
US5747292A (en) * | 1993-04-06 | 1998-05-05 | Fred Hutchinson Cancer Research Center | Chimeric cytokine receptors in lymphocytes |
WO2002056910A1 (en) * | 2001-01-17 | 2002-07-25 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
WO2013063419A2 (en) * | 2011-10-28 | 2013-05-02 | The Trustees Of The University Of Pennsylvania | A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
AU2013221672B2 (en) | 2012-02-13 | 2017-11-09 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
-
2017
- 2017-04-20 EP EP17724147.8A patent/EP3445847A1/en active Pending
- 2017-04-20 US US16/094,420 patent/US20190127435A1/en active Pending
- 2017-04-20 WO PCT/US2017/028693 patent/WO2017184901A1/en active Application Filing
- 2017-04-20 JP JP2018554677A patent/JP7198670B2/ja active Active
- 2017-04-20 CN CN201780037786.6A patent/CN109312304A/zh active Pending
- 2017-04-20 CA CA3021455A patent/CA3021455A1/en active Pending
-
2022
- 2022-09-01 JP JP2022139098A patent/JP2022164858A/ja active Pending